Extracellular vesicles in transfusion-related immunomodulation and the role of blood component manufacturing

Transfusion and Apheresis Science

Volumn 55, Issue 3, 2016, Pages 281-291

  Almizraq, Ruqayyah J ^a   Seghatchian, Jerard ^b   Acker, Jason P ^a,c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b International Consultancy in Blood Components Quality Safety Improvement   (United Kingdom)

^c CANADIAN BLOOD SERVICES   (Canada)

Author keywords

Blood storage; Microparticles; Microvesicles; Transfusion medicine; TRIM

Indexed keywords

BLOOD COMPONENT; BLOOD STORAGE; ERYTHROCYTE TRANSFUSION; EXOSOME; HUMAN; IMMUNE SYSTEM; IMMUNOMODULATION; MEMBRANE MICROPARTICLE; MORBIDITY; MORTALITY; RECIPIENT; TRANSFUSION MEDICINE; BLOOD COMPONENT THERAPY; ERYTHROCYTE; METABOLISM; RISK FACTOR;

BLOOD COMPONENT TRANSFUSION; ERYTHROCYTES; EXTRACELLULAR VESICLES; HUMANS; IMMUNOMODULATION; RISK FACTORS;

EID: 85004065593     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2016.10.018     Document Type: Review

References (158)

1. [1] Canadian Blood Services, 2014–2015 annual report: how we connect. 2015, 1–67.
2. [2] Hema-Quebec, Rapport annuel 2012–2013 d'Hema-Quebec. 2012, 1–154.
3. [3] World Health Organization, Global blood safety and availability fact sheet no. 279. Available from: http://www.who.int/mediacentre/factsheets/fs279/n/index.html, 2009.
4. [4] Raghavan, M., Marik, P.E., Anemia, allogenic blood transfusion, and immunomodulation in the critically ill. Chest 127 (2005), 295–307.
5. [5] Bennett-Guerrero, E., Zhao, Y., O'Brien, S.M., Ferguson, T.B., Peterson, E.D., Gammie, J.S., et al. Variation in the use of blood transfuion in coronary artery bypass graft surgery. J Am Med Assoc 304 (2010), 1568–1575.
6. [6] O'Brien, S.F., Yi, Q.L., Fan, W., Scalia, V., Fearon, M.A., Allain, J.P., Current incidence and residual risk of HIV, HBV and HCV at Canadian Blood Services. Vox Sang 103 (2012), 83–86.
7. [7] Kekre, N., Mallick, R., Allan, D., Tinmouth, A., Tay, J., The impact of prolonged storage of red blood cells on cancer survival. PLoS ONE, 8, 2013, e68820.
8. [8] Marik, P.E., Corwin, H.L., Efficacy of red blood cell transfusions in the critically ill: a systematic review of the literature. Crit Care Med 36 (2008), 2667–2674.
9. [9] Cata, J.P., Wang, H., Gottumukkala, V., Reuben, J., Sessler, D.I., Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions. Br J Anaesth 110 (2013), 690–701.
10. [10] Muszynski, J., Spinella, P., Colette, J., Acker, J.P., Hall, M., Juffermans, N., et al. What is transfusion-related immunomodulation in the pediatric intensive care unit?. Transfusion, 2016, 10.1111/trf.13855.
11. [11] Gilliss, B.M., Looney, M.R., Grooper, M.A., Reducing noninfectious risks of blood transfusion. Anesthesiology 115 (2011), 635–649.
12. [12] Vamvakas, E.C., Possible mechanisms of allogeneic blood transfusion-associated postoperative infection. Transfus Med Rev 16 (2002), 144–160.
13. [13] Chang, H., Hall, G.A., Geerts, W.H., Greenwood, C., McLeod, R.S., Sher, G.D., Allogeneic red blood cell transfusion is an independent risk factor for the development of postoperative bacterial infection. Vox Sang 78 (2000), 13–18.
14. [14] Carson, J.L., Altman, D.G., Duff, A., Noveck, H., Weinstein, M.P., Sonnenberg, F.A., et al. Risk of bacterial infection associated with allogeneic blood transfusion among patients undergoing hip fracture repair. Transfusion 39 (1999), 694–700.
15. [15] Lannan, K.L., Sahler, J., Spinelli, S.L., Phipps, R.P., Blumberg, N., Transfusion immunomodulation – the case for leukoreduced and (perhaps) washed transfusions. Blood Cells Mol Dis 50 (2013), 61–68.
16. [16] Blajchman, M.A., Allogeneic blood transfusions, immunomodulation, and postoperative bacterial infection; Do we have the answers yet?. Transfusion 37 (1997), 121–125.
17. [17] Blajchman, M.A., Immunomodulation and blood transfusion. Am J Ther 9 (2002), 389–395.
18. [18] Chargaff, E., West, R., The biological significance of the thromboplastic protein of blood. J Biol Chem 166 (1946), 189–197.
19. [19] van der Pol, E., Boing, A.N., Harrison, P., Sturk, A., Nieuwland, R., Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol Rev 64 (2012), 676–705.
20. [20] Wolf, P., The nature and significance of platelet products in human plasma. Br J Haematol 13 (1967), 269–288.
21. [21] de Vooght, K.M., Lau, C., de Laat, P.P., van Wijk, R., van Solinge, W.W., Schiffelers, R.M., Extracellular vesicles in the circulation: are erythrocyte microvesicles a confounder in the plasma haemoglobin assay?. Biochem Soc Trans 41 (2013), 288–292.
22. [22] Burger, D., Schock, S., Thompson, C.S., Montezano, A.C., Hakim, A.M., Touyz, R.M., Microparticles: biomarkers and beyond. Clin Sci 124 (2013), 423–441.
23. [23] Johnstone, R.M., Adam, M., Hammond, J.R., Orr, L., Turbide, C., Vesicle formation during reticulocyte maturation – association of plasma-membrane activities with released vesicles (exosomes). J Biol Chem 262 (1987), 9412–9420.
24. [24] Denzer, K., Kleijmeer, M.J., Heijnen, H.F.G., Stoorvogel, W., Geuze, H.J., Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. J Cell Sci 113 (2000), 3365–3374.
25. [25] Koseoglu, S., Flaumenhaft, R., Advances in platelet granule biology. Curr Opin Hematol 20 (2013), 464–471.
26. [26] Canellini, G., Rubin, O., Delobel, J., Crettaz, D., Lion, N., Tissot, J.D., Red blood cell microparticles and blood group antigens: an analysis by flow cytometry. Blood Transfus 10:Suppl. 2 (2012), s39–45.
27. [27] Momen-Heravi, F., Balaj, L., Alian, S., Mantel, P.Y., Halleck, A.E., Trachtenberg, A.J., et al. Current methods for the isolation of extracellular vesicles. Biol Chem 394 (2013), 1253–1262.
28. [28] Yuana, Y., Koning, R.I., Kuil, M.E., Rensen, P.C., Koster, A.J., Bertina, R.M., et al. Cryo-electron microscopy of extracellular vesicles in fresh plasma. J Extracell Vesicles, 2, 2013.
29. [29] Kastelowitz, N., Yin, H., Exosomes and microvesicles: identification and targeting by particle size and lipid chemical probes. Chembiochem 15 (2014), 923–928.
30. [30] Van Der Pol, E., Coumans, F., Varga, Z., Krumrey, M., Nieuwland, R., Innovation in detection of microparticles and exosomes. J Thromb Haemost 11 (2013), 36–45.
31. [31] Haqqani, A.S., Delaney, C.E., Tremblay, T.L., Sodja, C., Sandhu, J.K., Stanimirovic, D.B., Method for isolation and molecular characterization of extracellular microvesicles released from brain endothelial cells. Fluids Barriers CNS, 10, 2013, 4.
32. [32] De Jong, O.G., Van Balkom, B.W., Schiffelers, R.M., Bouten, C.V., Verhaar, M.C., Extracellular vesicles: potential roles in regenerative medicine. Front Immunol, 5, 2014, 608.
33. [33] Urbanelli, L., Magini, A., Buratta, S., Brozzi, A., Sagini, K., Polchi, A., et al. Signaling pathways in exosomes biogenesis, secretion and fate. Genes (Basel) 4 (2013), 152–170.
34. [34] Booth, A.M., Fang, Y., Fallon, J.K., Yang, J.M., Hildreth, J.E.K., Gould, S.J., Exosomes and HIV Gag bud from endosome-like domains of the T cell plasma membrane. J Cell Biol 172 (2006), 923–935.
35. [35] Stoorvogel, W., Kleijmeer, M.J., Geuze, H.J., Raposo, G., The biogenesis and functions of exosomes. Traffic 3 (2002), 321–330.
36. [36] Knowles, D.W., Tilley, L., Mohandas, N., Chasis, J.A., Erythrocyte membrane vesiculation: model for the molecular mechanism of protein sorting. Proc Natl Acad Sci USA 94 (1997), 12969–12974.
37. [37] Heijnen, H.F.G., Debili, N., Vainchencker, W., Breton-Gorius, J., Geuze, H.J., Sixma, J.J., Multivesicular bodies are an intermediate stage in the formation of platelet alpha-granules. Blood 91 (1998), 2313–2325.
38. [38] Blair, P., Flaumenhaft, R., Platelet alpha-granules: basic biology and clinical correlates. Blood Rev 23 (2009), 177–189.
39. [39] Morel, O., Jesel, L., Freyssinet, J.M., Toti, F., Cellular mechanisms underlying the formation of circulating microparticles. Arterioscler Thromb Vasc Biol 31 (2011), 15–26.
40. [40] Jimenez, J.J., Jy, W., Mauro, L.M., Soderland, C., Horstman, L.L., Ahn, Y.S., Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb Res 109 (2003), 175–180.
41. [41] Raposo, G., Tenza, D., Mecheri, S., Peronet, R., Bonnerot, C., Desaymard, C., Accumulation of major histocompatibility complex class II molecules in mast cell secretory granules and their release upon degranulation. Mol Biol Cell 8 (1997), 2631–2645.
42. [42] Savina, A., Furlan, M., Vidal, M., Colombo, M.I., Exosome release is regulated by a calcium-dependent mechanism in K562 cells. J Biol Chem 278 (2003), 20083–20090.
43. [43] Lee, J.S., Gladwin, M.T., Bad blood: the risks of red cell storage. Nat Med 16 (2010), 381–382.
44. [44] Kriebardis, A., Antonelou, M., Stamoulis, K., Papassideri, I., Cell-derived microparticles in stored blood products: innocent-bystanders or effective mediators of post-transfusion reactions?. Blood Transfus 10 (2012), S25–38.
45. [45] Nascimbene, A., Hernandez, R., George, J.K., Parker, A., Bergeron, A.L., Pradhan, S., et al. Association between cell-derived microparticles and adverse events in patients with nonpulsatile left ventricular assist devices. J Heart Lung Transplant 33 (2014), 470–477.
46. [46] Danesh, A., Inglis, H.C., Jackman, R.P., Wu, S.Q., Deng, X.T., Muench, M.O., et al. Exosomes from red blood cell units bind to monocytes and induce proinflammatory cytokines, boosting T-cell responses in vitro. Blood 123 (2014), 687–696.
47. [47] Alaarg, A., Schiffelers, R., van Solinge, W.W., Van Wijk, R., Red blood cell vesiculation in hereditary hemolytic anemia. Front Physiol, 4, 2013.
48. [48] Flatt, J.F., Bawazir, W.M., Bruce, L.J., The involvement of cation leaks in the storage lesion of red blood cells. Front Physiol, 5, 2014.
49. [49] Pan, B.T., Johnstone, R.M., Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor. Cell 33 (1983), 967–978.
50. [50] Johnstone, R.M., Mathew, A., Mason, A.B., Teng, K., Exosome formation during maturation of mammalian and avian reticulocytes: evidence that exosome release is a major route for externalization of obsolete membrane proteins. J Cell Physiol 147 (1991), 27–36.
51. [51] Raposo, G., Stoorvogel, W., Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol 200 (2013), 373–383.
52. [52] Thery, C., Amigorena, S., Raposo, G., Clayton, A., Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol, 2006 Chapter 3:Unit 3:22.
53. [53] Lee, Y., El Andaloussi, S., Wood, M.J., Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy. Hum Mol Genet 21 (2012), R125–34.
54. [54] El Andaloussi, S., Maeger, I., Breakefield, X.O., Wood, M.J.A., Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov 12 (2013), 348–358.
55. [55] Balaj, L., Lessard, R., Dai, L.X., Cho, Y.J., Pomeroy, S.L., Breakefield, X.O., et al. Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. Nat Commun, 2, 2011.
56. [56] Momen-Heravi, F., Balaj, L., Alian, S., Tigges, J., Toxavidis, V., Ericsson, M., et al. Alternative methods for characterization of extracellular vesicles. Front Physiol, 3, 2012, 354.
57. [57] Choi, D.S., Kim, D.K., Kim, Y.K., Gho, Y.S., Proteomics, transcriptomics and lipidomics of exosomes and ectosomes. Proteomics 13 (2013), 1554–1571.
58. [58] Ardoin, S.P., Shanahan, J.C., Pisetsky, D.S., The role of microparticles in inflammation and thrombosis. Scand J Immunol 66 (2007), 159–165.
59. [59] Mathivanan, S., Ji, H., Simpson, R.J., Exosomes: extracellular organelles important in intercellular communication. J Proteomics 73 (2010), 1907–1920.
60. [60] Gangoda, L., Boukouris, S., Liem, M., Kalra, H., Mathivanan, S., Extracellular vesicles including exosomes are mediators of signal transduction: are they protective or pathogenic?. Proteomics 15 (2015), 260–271.
61. [61] Kalra, H., Simpson, R.J., Ji, H., Aikawa, E., Altevogt, P., Askenase, P., et al. Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol, 10, 2012.
62. [62] Franquesa, M., Hoogduijn, M.J., Ripoll, E., Luk, F., Salih, M., Betjes, M.G., et al. Update on controls for isolation and quantification methodology of extracellular vesicles derived from adipose tissue mesenchymal stem cells. Front Immunol, 5, 2014, 525.
63. [63] Zhang, B., Yin, Y., Lai, R.C., Lim, S.K., Immunotherapeutic potential of extracellular vesicles. Front Immunol, 5, 2014, 518.
64. [64] van der Meel, R., Fens, M.H.A.M., Vader, P., van Solinge, W.W., Eniola-Adefeso, O., Schiffelers, R.M., Extracellular vesicles as drug delivery systems: lessons from the liposome field. J Control Release 195 (2014), 72–85.
65. [65] Maas, S.L., de Vrij, J., van der Vlist, E.J., Geragousian, B., van Bloois, L., Mastrobattista, E., et al. Possibilities and limitations of current technologies for quantification of biological extracellular vesicles and synthetic mimics. J Control Release 200 (2015), 87–96.
66. [66] Zocco, D., Ferruzzi, P., Cappello, F., Kuo, W.P., Fais, S., Extracellular vesicles as shuttles of tumor biomarkers and anti-tumor drugs. Front Oncol, 4, 2014, 267.
67. [67] Johnsen, K.B., Gudbergsson, J.M., Skov, M.N., Pilgaard, L., Moos, T., Duroux, M., A comprehensive overview of exosomes as drug delivery vehicles – endogenous nanocarriers for targeted cancer therapy. Biochim Biophys Acta 1846 (2014), 75–87.
68. [68] van Dommelen, S.M., Vader, P., Lakhal, S., Kooijmans, S.A.A., van Solinge, W.W., Wood, M.J.A., et al. Microvesicles and exosomes: opportunities for cell-derived membrane vesicles in drug delivery. J Control Release 161 (2012), 635–644.
69. [69] Valadi, H., Ekstrom, K., Bossios, A., Sjostrand, M., Lee, J.J., Lotvall, J.O., Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9 (2007), 654–659.
70. [70] Cocucci, E., Racchetti, G., Meldolesi, J., Shedding microvesicles: artefacts no more. Trends Cell Biol 19 (2009), 43–51.
71. [71] Kooijmans, S.A.A., Vader, P., van Dommelen, S.M., van Solinge, W.W., Schiffelers, R.M., Exosome mimetics: a novel class of drug delivery systems. Int J Nanomedicine 7 (2012), 1525–1541.
72. [72] Skog, J., Wurdinger, T., van Rijn, S., Meijer, D.H., Gainche, L., Curry, W.T., et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 10 (2008), 1470–1476.
73. [73] Baj-Krzyworzeka, M., Szatanek, R., Weglarczyk, K., Baran, J., Urbanowicz, B., Branski, P., et al. Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes. Cancer Immunol Immunother 55 (2006), 808–818.
74. [74] Ratajczak, J., Miekus, K., Kucia, M., Zhang, J., Reca, R., Dvorak, P., et al. Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia 20 (2006), 847–856.
75. [75] Ge, Q.Y., Zhou, Y.X., Lu, J.F., Bai, Y.F., Xie, X.Y., Lu, Z.H., miRNA in plasma exosome is stable under different storage conditions. Molecules 19 (2014), 1568–1575.
76. [76] Clayton, A., Harris, C.L., Court, J., Mason, M.D., Morgan, B.P., Antigen-presenting cell exosomes are protected from complement-mediated lysis by expression of CD55 and CD59. Eur J Immunol 33 (2003), 522–531.
77. [77] Meckes, D.G., Raab-Traub, N., Microvesicles and viral infection. J Virol 85 (2011), 12844–12854.
78. [78] Loyer, X., Vion, A.C., Tedgui, A., Boulanger, C.M., Microvesicles as cell-cell messengers in cardiovascular diseases. Circ Res 114 (2014), 345–353.
79. [79] Fernandez-Messina, L., Gutierrez-Vazquez, C., Rivas-Garcia, E., Sanchez-Madrid, F., de la Fuente, H., Immunomodulatory role of microRNAs transferred by extracellular vesicles. Biol Cell 107 (2015), 61–77.
80. [80] Tetta, C., Ghigo, E., Silengo, L., Deregibus, M.C., Camussi, G., Extracellular vesicles as an emerging mechanism of cell-to-cell communication. Endocrine 44 (2013), 11–19.
81. [81] Jong-Kuen, L., Ji-Young, J., Yoon-Kyung, J., Chul-Woo, K., Extracellular vesicles as an emerging paradigm of cell-to-cell communication in stem cell biology. J Stem Cell Res Ther 4 (2014), 1–5.
82. [82] Ratajczak, J., Wysoczynski, M., Hayek, F., Janowska-Wieczorek, A., Ratajczak, M.Z., Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 20 (2006), 1487–1495.
83. [83] Turturici, G., Tinnirello, R., Sconzo, G., Geraci, F., Extracellular membrane vesicles as a mechanism of cell-to-cell communication: advantages and disadvantages. Am J Physiol Cell Physiol 306 (2014), C621–33.
84. [84] Aatonen, M., Gronholm, M., Siljander, P.R.M., Platelet-derived microvesicles: multitalented participants in intercellular communication. Semin Thromb Hemost 38 (2012), 102–113.
85. [85] Record, M., Subra, C., Silvente-Poirot, S., Poirot, M., Exosomes as intercellular signalosomes and pharmacological effectors. Biochem Pharmacol 81 (2011), 1171–1182.
86. [86] Small, E.M., Olson, E.N., Pervasive roles of microRNAs in cardiovascular biology. Nature 469 (2011), 336–342.
87. [87] Yamamoto, S., Niida, S., Azuma, E., Yanagibashi, T., Muramatsu, M., Huang, T.T., et al. Inflammation-induced endothelial cell-derived extracellular vesicles modulate the cellular status of pericytes. Sci Rep, 5, 2015.
88. [88] Refaai, M.A., Blumberg, N., Transfusion immunomodulation from a clinical perspective: an update. Expert Rev Hematol 6 (2013), 653–663.
89. [89] Sparrow, R.L., Red blood cell storage and transfusion-related immunomodulation. Blood Transfus 8 (2010), S26–30.
90. [90] Opelz, G., Sengar, D.P., Mickey, M.R., Terasaki, P.I., Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 5 (1973), 253–259.
91. [91] Dasararaju, R., Marques, M.B., Adverse effects of transfusion. Cancer Control 22 (2015), 16–25.
92. [92] Hod, E.A., Spitalnik, S.L., Stored red blood cell transfusions: iron, inflammation, immunity, and infection. Transfus Clin Biol 19 (2012), 84–89.
93. [93] Jy, W., Ricci, M., Shariatmadar, S., Gomez-Marin, O., Horstman, L.H., Ahn, Y.S., Microparticles in stored red blood cells as potential mediators of transfusion complications. Transfusion 51 (2011), 886–893.
94. [94] Krailadsiri, P., Seghatchian, J., Bode, A.P., Microvesicles in blood components: laboratory and clinical aspects. Clin Appl Thromb Hemost 3 (1997), 86–95.
95. [95] Belizaire, R.M., Prakash, P.S., Richter, J.R., Robinson, B.R., Edwards, M.J., Caldwell, C.C., et al. Microparticles from stored red blood cells activate neutrophils and cause lung injury after hemorrhage and resuscitation. J Am Coll Surg 214 (2012), 648–655.
96. [96] Vamvakas, E.C., Blajchman, M.A., Transfusion-related immunomodulation (TRIM): an update. Blood Rev 21 (2007), 327–348.
97. [97] Sugawara, A., Nollet, K.E., Yajima, K., Saito, S., Ohto, H., Preventing platelet-derived microparticle formation – and possible side effects – with prestorage leukofiltration of whole blood. Arch Pathol Lab Med 134 (2010), 771–775.
98. [98] Cardo, L.J., Wilder, D., Salata, J., Neutrophil priming, caused by cell membranes and microvesicles in packed red blood cell units, is abrogated by leukocyte depletion at collection. Transfus Apher Sci 38 (2008), 117–125.
99. [99] Hunter, M.P., Ismail, N., Zhang, X.L., Aguda, B.D., Lee, E.J., Yu, L.B., et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS ONE, 3, 2008.
100. [100] Sprague, D.L., Elzey, B.D., Crist, S.A., Waldschmidt, T.J., Jensen, R.J., Ratliff, T.L., Platelet-mediated modulation of adaptive immunity: unique delivery of CD154 signal by platelet-derived membrane vesicles. Blood 111 (2008), 5028–5036.
101. [101] Yuana, Y., Sturk, A., Nieuwland, R., Extracellular vesicles in physiological and pathological conditions. Blood Rev 27 (2013), 31–39.
102. [102] Arraud, N., Linares, R., Tan, S., Gounou, C., Pasquet, J.M., Mornet, S., et al. Extracellular vesicles from blood plasma: determination of their morphology, size, phenotype and concentration. J Thromb Haemost 12 (2014), 614–627.
103. [103] Xiong, Z.Y., Cavaretta, J., Qu, L.R., Stolz, D.B., Triulzi, D., Lee, J.S., Red blood cell microparticles show altered inflammatory chemokine binding and release ligand upon interaction with platelets. Transfusion 51 (2011), 610–621.
104. [104] Muszynski, J.A., Bale, J., Nateri, J., Nicol, K., Wang, Y., Wright, V., et al. Supernatants from stored red blood cell (RBC) units, but not RBC-derived microvesicles, suppress monocyte function in vitro. Transfusion 55 (2015), 1937–1945.
105. [105] Antonelou, M.H., Kriebardis, A.G., Papassideri, I.S., Aging and death signalling in mature red cells: from basic science to transfusion practice. Blood Transfus 8:Suppl. 3 (2010), s39–47.
106. [106] Scott, K.L., Lecak, J., Acker, J.P., Biopreservation of red blood cells: past, present, and future. Transfus Med Rev 19 (2005), 127–142.
107. [107] Donadee, C., Raat, N.J., Kanias, T., Tejero, J., Lee, J.S., Kelley, E.E., et al. Nitric oxide scavenging by red blood cell microparticles and cell-free hemoglobin as a mechanism for the red cell storage lesion. Circulation 124 (2011), 465–476.
108. [108] Kim-Shapiro, D.B., Lee, J., Gladwin, M.T., Storage lesion: role of red blood cell breakdown. Transfusion 51 (2011), 844–851.
109. [109] Sowemimo-Coker, S.O., Red blood cell hemolysis during processing. Transfus Med Rev 16 (2002), 46–60.
110. [110] Gladwin, M.T., Kanias, T., Kim-Shapiro, D.B., Hemolysis and cell-free hemoglobin drive an intrinsic mechanism for human disease. J Clin Invest 122 (2012), 1205–1208.
111. [111] Yu, B.L., Lei, C., Baron, D.M., Steinbicker, A.U., Bloch, K.D., Zapol, W.M., Diabetes augments and inhaled nitric oxide prevents the adverse hemodynamic effects of transfusing syngeneic stored blood in mice. Transfusion 52 (2012), 1410–1422.
112. [112] Kanias, T., Gladwin, M.T., Nitric oxide, hemolysis, and the red blood cell storage lesion: interactions between transfusion, donor, and recipient. Transfusion 52 (2012), 1388–1392.
113. [113] Baek, J.H., D'Agnillo, F., Vallelian, F., Pereira, C.P., Williams, M.C., Jia, Y.P., et al. Hemoglobin-driven pathophysiology is an in vivo consequence of the red blood cell storage lesion that can be attenuated in guinea pigs by haptoglobin therapy. J Clin Invest 122 (2012), 1444–1458.
114. [114] Greenwalt, T.J., McGuinness, C.G., Dumaswala, U.J., Studies in red blood cell preservation: 4. Plasma vesicle hemoglobin exceeds free hemoglobin. Vox Sang 61 (1991), 14–17.
115. [115] Hod, E.A., Zhang, N., Sokol, S.A., Wojczyk, B.S., Francis, R.O., Ansaldi, D., et al. Transfusion of red blood cells after prolonged storage produces harmful effects that are mediated by iron and inflammation. Blood 115 (2010), 4284–4292.
116. [116] Doctor, A., Spinella, P., Effect of processing and storage on red blood cell function in vivo. Semin Perinatol 36 (2012), 248–259.
117. [117] Almizraq, R., Tchir, J.D., Holovati, J.L., Acker, J.P., Storage of red blood cells affects membrane composition, microvesiculation, and in vitro quality. Transfusion 53 (2013), 2258–2267.
118. [118] Simak, J., Gelderman, M.P., Cell membrane microparticles in blood and blood products: potentially pathogenic agents and diagnostic markers. Transfus Med Rev 20 (2006), 1–26.
119. [119] Keating, F.K., Butenas, S., Fung, M., Schneider, D.J., Platelet-white blood cell (WBC) interaction, WBC apoptosis, and procoagulant activity in stored red blood cells. Transfusion 51 (2011), 1086–1095.
120. [120] Waugh, R., Narla, M., Jackson, C., Mueller, T., Suzuki, T., Dale, G.L., Rheological properties of senescent erythrocytes: loss of surface area and volume with red blood cell age. Blood 79 (1992), 1351–1358.
121. [121] Lacroix, J., Hebert, P., Fergusson, D., Tinmouth, A., Blajchman, M.A., Callum, J., et al. The age of blood evaluation (ABLE) randomized controlled trial: study design. Transfus Med Rev 25 (2011), 197–205.
122. [122] Steiner, M., Red cell storage duration (RECESS). Available from: http://www.clinicaltrials.gov/ct2/results?term=NCT00991341, 2011.
123. [123] Koch, C., Red cell storage duration and outcomes in cardiac surgery. Available from: http://www.clinicaltrials.gov/ct2/results?term=nct00458783, 2011.
124. [124] Aubron, C., Syres, G., Nichol, A., Bailey, M., Board, J., Magrin, G., et al. A pilot feasibility trial of allocation of freshest available red blood cells versus standard care in critically ill patients. Transfusion 52 (2012), 1196–1202.
125. [125] Chabanel, A., Masse, M., Begue, S., National French observatory of the quality of blood components for transfusion. Transfus Clin Biol 15 (2008), 85–90.
126. [126] Radwanski, K., Cognasse, F., Garraud, O., Payrat, J.M., Min, K., Comparison of apheresis and 24 h RT held red cell concentrates by measurement of storage lesion parameters and neutrophil activating factors during 42-day storage. Transfus Apher Sci, 48, 2013, 169.
127. [127] Högman, C.F., Eriksson, L., Hedlund, K., Wallvik, J., The bottom and top system: a new technique for blood component preparation and storage. Vox Sang 55 (1988), 211–217.
128. [128] Bennardello, F., Fidone, C., Spadola, V., Cabibbo, S., Travali, S., Garozzo, G., et al. The prevention of adverse reactions to transfusions in patients with haemoglobinopathies: a proposed algorithm. Blood Transfus 11 (2013), 377–384.
129. [129] D'Amici, G.M., Mirasole, C., D'Alessandro, A., Yoshida, T., Dumont, L.J., Zolla, L., Red blood cell storage in SAGM and AS3: a comparison through the membrane two-dimensional electrophoresis proteome. Blood Transfus 10:Suppl. 2 (2012), s46–54.
130. [130] Hess, J.R., An update on solutions for red cell storage. Vox Sang 91 (2006), 13–19.
131. [131] Högman, C.F., Liquid-stored red blood cells for transfusion: a status report. Vox Sang 76 (1999), 67–77.
132. [132] Sweeney, J.D., Quality assurance and standards for red cells and platelets. Vox Sang 74 (1998), 201–205.
133. [133] Jordan, A., Chen, D., Yi, Q.-L., Acker, J.P., Assessing the influence of component processing and donor characteristics on red cell concentrates using quality control data. Vox Sang 111 (2016), 8–15.
134. [134] van de Watering, L., Effects of red blood cell storage in heavily transfused patients. Curr Opin Anaesthesiol 26 (2013), 204–207.
135. [135] Hansen, A.L., Kurach, J.D., Turner, T.R., Jenkins, C., Busch, M.P., Norris, P.J., et al. The effect of processing method on the in vitro characteristics of red blood cell products. Vox Sang 108 (2015), 350–358.
136. [136] Acker, J.P., Hansen, A.L., Kurach, J.D., Turner, T.R., Croteau, I., Jenkins, C., A quality monitoring program for red blood cell components: in vitro quality indicators before and after implementation of semiautomated processing. Transfusion 54 (2014), 2534–2543.
137. [137] Bicalho, B., Pereira, A.S., Acker, J.P., Buffy coat (top/bottom)- and whole-blood filtration (top/top)-produced red cell concentrates differ in size of extracellular vesicles. Vox Sang 109 (2015), 214–220.
138. [138] Heddle, N.M., Arnold, D.M., Acker, J.P., Liu, Y., Barty, R.L., Eikelboom, J.W., et al. Red blood cell processing methods and in-hospital mortality: a transfusion registry cohort study. Lancet Haematol 3 (2016), e246–54.
139. [139] Dumaswala, U.J., Dumaswala, R.U., Levin, D.S., Greenwalt, T.J., Improved red blood cell preservation correlates with decreased loss of bands 3, 4.1, acetylcholinestrase, and lipids in microvesicles. Blood 87 (1996), 1612–1616.
140. [140] Lutz, H.U., Liu, S.C., Palek, J., Release of spectrin-free vesicles from human erythrocytes during ATP depletion. I. Characterization of spectrin-free vesicles. J Cell Biol 73 (1977), 548–560.
141. [141] Greenwalt, T.J., Bryan, D.J., Dumaswala, U.J., Erythrocyte membrane vesiculation and changes in membrane composition during storage in citrate-phosphate-dextrose-adenine-1. Vox Sang 47 (1984), 261–270.
142. [142] Bicalho, B., Holovati, J.L., Acker, J.P., Phospholipidomics reveals differences in glycerophosphoserine profiles of hypothermically stored red blood cells and microvesicles. Biochim Biophys Acta 1828 (2013), 317–326.
143. [143] Bakkour, S., Acker, J.P., Chafets, D.M., Inglis, H.C., Norris, P.J., Busch, M.P., Manufacturing method affects mitochondrial DNA release and extracellular vesicle composition in stored red blood cells. Vox Sang 111 (2016), 22–32.
144. [144] Rubin, O., Crettaz, D., Canellini, G., Tissot, J.D., Lion, N., Microparticles in stored red blood cells: an approach using flow cytometry and proteomic tools. Vox Sang 95 (2008), 288–297.
145. [145] Kriebardis, A.G., Antonelou, M.H., Stamoulis, K.E., Economou-Petersen, E., Margaritis, L.H., Papassideri, I.S., RBC-derived vesicles during storage: ultrastructure, protein composition, oxidation, and signaling components. Transfusion 48 (2008), 1943–1953.
146. [146] Sonker, A., Dubey, A., Chaudhary, R., Evaluation of a red cell leukofilter performance and effect of buffy coat removal on filtration efficiency and post-filtration storage. Indian J Hematol Blood Transfus 30 (2014), 321–327.
147. [147] Neal, M.D., Raval, J.S., Triulzi, D., Simmons, R.L., Innate immune activation after transfusion of stored red blood cells. Transfus Med Rev 27 (2013), 113–118.
148. [148] Wadhwa, M., Seghatchian, M.J., Dilger, P., Contreras, M., Thorpe, R., Cytokine accumulation in stored red cell concentrates: effect of buffy-coat removal and leucoreduction. Transfus Sci 23 (2000), 7–16.
149. [149] Setty, B.N.Y., Betal, S.G., Microvascular endothelial cells express a phosphatidylserine receptor: a functionally active receptor of phosphatidylserine-positive erythrocytes. Blood 111 (2008), 905–914.
150. [150] Rubin, O., Delobel, J., Prudent, M., Lion, N., Kohl, K., Tucker, E.I., et al. Red blood cell-derived microparticles isolated from blood units initiate and propagate thrombin generation. Transfusion 53 (2013), 1744–1754.
151. [151] Puddu, P., Puddu, G.M., Cravero, E., Muscari, S., Muscari, A., The involvement of circulating microparticles in inflammation, coagulation and cardiovascular diseases. Can J Cardiol 26 (2010), e140–5.
152. [152] Silliman, C.C., Moore, E.E., Kelher, M.R., Khan, S.Y., Gellar, L., Elzi, D.J., Identification of lipids that accumulate during the routine storage of prestorage leukoreduced red blood cells and cause acute lung injury. Transfusion 51 (2011), 2549–2554.
153. [153] Allen, J.G., Lee, M.T., Weiss, E.S., Arnaoutakis, G.J., Shah, A.S., Detrick, B., Preoperative recipient cytokine levels are associated with early lung allograft dysfunction. Ann Thorac Surg 93 (2012), 1843–1849.
154. [154] Muldrew, K., Novak, K., Yang, H., Zernicke, R., Schachar, N.S., McGann, L.E., Cryobiology of articular cartilage: ice morphology and recovery of chondrocytes. Cryobiology 40 (2000), 102–109.
155. [155] Cortés-Puch, I., Wang, D., Sun, J., Solomon, S.B., Remy, K.E., Fernandez, M., et al. Washing older blood units before transfusion reduces plasma iron and improves outcomes in experimental canine pneumonia. Blood 123 (2014), 1403–1411.
156. [156] Hansen, A.L., Turner, T.R., Yi, Q.-L., Acker, J.P., Quality of red blood cells washed using an automated cell processor with and without irradiation. Transfusion 54 (2014), 1585–1594.
157. [157] Hansen, A., Yi, Q.-L., Acker, J.P., Quality of red blood cells washed using the ACP 215 cell processor: assessment of optimal pre- and postwash storage times and conditions. Transfusion 53 (2013), 1772–1779.
158. [158] Vlaar, A.P.J., Hofstra, J.J., Levi, M., Kulik, W., Nieuwland, R., Tool, A.T.J., et al. Supernatant of aged erythrocytes causes lung inflammation and coagulopathy in a “two-hit” in vivo syngeneic transfusion model. Anesthesiology 113 (2010), 92–103.